University of Oklahoma Health Sciences Center
http://www.ouhsc.edu
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From University of Oklahoma Health Sciences Center
AF Ablation: Finding the Right Mix
For a number of reasons, 2009 was a big year for the atrial fibrillation ablation market. Early in the year, Biosense Webster received FDA approval for its radiofrequency ablation catheter, the first such device to launch in the US with a specific AF indication. That approval was much more than just a landmark event for J&J; it changed the landscape of the AF industry, reinvigorating interest in the funding and development of new catheter-based technologies--a trend that has extended through to 2010 and will likely continue in the years ahead.
Recent Financings of Private Companies (11/2007)
Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.
EuroPACE Highlights: AF Cath Ablation Interest Heats Up
Catheter ablation dominated the biannual EuroPACE meeting held in Lisbon at the end of June. In addition to the range of manual catheter ablation systems, remote catheter navigation and mapping also attracted large audiences.
Company Information
- Industry
- Academic and Research Institutions
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice